PH in the Real World
Case Studies
Terry Fortin MD
Duke Pulmonary Vascular Disease Center
November 4, 2022
• Mean PAP > 20 mmHg
1
• Wedge < 15 mmHg
2
• PVR > 3 WU (or less)
3
Definition of PAH Clinical, Hemodynamic
6th World Symposium 2018
6th World Symposium on PH 2018
Groups of PH (Framework)
 1. Pulmonary Arterial Hypertension (PAH)
 2. PH owing to left heart disease
 3. PH owing to lung diseases and/or
hypoxia
 4. Chronic thromboembolic pulmonary
hypertension (CTEPH)
 5. PH with unclear multifactorial mechanisms
 (ESRD, Cancer, Hemoglobinopathy, Sarcoid…
Real World : PH or PAH ?
54 yo sickle cell/thallasemia Hgb 7-8
Rheumatoid arthritis SLE overlap/MCTD
CKD on hemodialysis (high output)
History Mitral Valve replacement for remote
endocarditis
Morbid obesity, (BMI>50) OSA on CPAP
LV EF is 45%, HTN, DM, TIA, CAD
Pulmonary embolus x 2 but VQ neg
PFDs with moderate restrictive/ obstructive
lung disease.
Later develops cirrhosis
WCM How did we get from A
to B. What if B came first?
 RH Cath 4/22
 RA 22
 RV 110/20
 PA 104/45 mean 68
 PCWP 28
 Output 7 L/min
 Index 3.2
 PVR 5.7 WU
 ABG 7.25/90/107
 Hgb 17.9
 RH Cath 7/22
 RA 8
 RV 50/10
 PA 52/29 mean 34
 Wedge 14
 output 5.2 L/min
 Index 2.5
 PVR 3.9
WCM 4/2022
 65 yo presents to OSH with “COPD flare and NSTEMI”
 EMS called nonresponsive, 02 sat 60% Placed on BiPAP
 History COPD since 2017, Flare 1-2 times per year . Not on 02
 At OSH ABG 7.1/88/124 on 02
 Elevated troponins, LFTs, AKI, pBNP 1700, Hgb 18
 CT ruled out PE, No pneumonia
 History of sleep apnea x years but never used machine
 On inhalers for COPD No PFDs
 On transfer hypercarbic and hypoxic respiratory failure.
 Diuresis, on /off bipap, ABX and Steroids
WCM
WCM Right and Left Heart Cath 4/2022
Off BIPAP on FI02 30%
 RA 22
 RV 110/20
 PA 104/45 mean 68
 PCWP 28
 AO 129/80 mean 96
 CO 7 L/min CI 3.2
 PVR 5.7 WU No Step up to suggest Shunt
 7.25/90/107 Hgb 17.9 Sat 95%
 Placed back on BIPAP post case
 Two vessel CAD TIMI 3 Flow 80% mid LCx,
 Tandom 80% RCA proximal and mid lesions
 Negative volume about 3 liters+ by this time
Pulmonary Vascular Resistance (PVR) increases
with
hypoxemia,
acidosis,
hypercarbia,
increased catacholamines or sympathetic tone
Illness , inflammation,
Thrombosis
 Very high or low lung volumes increase PVR
Activation of neurohormones negatively impacts
function of RV as well
Relevant principles
Treatment???
 Diuresis
 Give pulmonary vasodilator (inhaled prostacyclin)
 1 and then 2
 Diuresis, initiate CPAP/BIPAP/Trilogy
 IV Prostacyclin
 Dual oral therapy with endothelin antagonist and PDE 5
inhibitor
 Repeat Cath before Discharge?
 More Work up
 CT with No PE, ANA normal, HIV normal, Some ongoing
work up for liver disease
 Had stents to his RCA and LCx
My Plan
 Diuresis
 Sent home with Trilogy Machine
 02 for exertion Per PT assessment
 Shock Liver resolved. AKI resolved
 VBG before Discharge 7.43 pC02 48 post using trilogy in
hospital
 Follow up with Pulmonologist / Sleep
 Seen back in my clinic in 10 Days
 Decreased diuretic, pBNP much improved
 Feeling best he has been in years
 Plan for repeat Right heart cath after on his Sleep machine
for 2 to 3 months as long as he is well
WCM 1st clinic visit
 PFDs Group 3 Disease
 FVC 3.33 L 76%
 FEV1 1.28 L 38%
 FEV1/FVC 38
 FEF25-7% 14%
 TLC 110%
 RV 178%
 DLCO 13.72 52%
 Walk is 393 meters (76% predicated)room air
WCM RH Cath 7/2022
 RA 8, PA 52/29 mean 34, Wedge 14
 Cardiac output is 5.2L/min with index of 2.4
 PVR is 3.9 WU, SVR 13 with mean BP of 78
 TPG 20, DPG 15
 pBNP is 148 ( down from 1700)
 Previous cath pre trilogy and diuresis
 RA 22, Mean PAP 68, wedge 28 (group 2)
 Passive or Post Capillary pressures cause congestion of
venous bed and passive PH
 Increased PA pressure with high wedge normal PVR
 Can then have reversible vasoconsttriction
 TPG < 12 and /or DPD or DPG <7
Reactive or precapillary PH physiologic/anatomic remodeling of
arterioles to compensate or protect upstream pulmonary
venous changes
 PVR>3, TPG >12, DPD or DPG >7
 Early may be reversible and more Chronic irreversible
 Combined pre and post capillary PH
Group 2 Pulmonary HTN
WCM Sep 2022
 Normalization of p BNP pBNP 143 ( < 225 normal)
 ANA negative, Alpha -1 Antitrypsin normal
 Negative VQ
 Bicarb decreased from 35 to 27
 Work up for Liver Disease /Steatohepatitis
 Completed cardiopulmonary Rehab
 No Hospitalizations or COPD flares since 4/22
 Compliant with CPAP
 Set up for echo next visit
WCM
 What Group At least Group 2 and 3 ?1
 Pre and post capillary PH Initially more Pre
 TPG 68-28 =44
 DPG 45-24 = 11
 But high wedge 28
 Does it matter that his pH was 7.25, and pC02 90?
 Group 3
 Sleep issues
 COPD ( Would this be different if ILD)
 VQ was low probability
Patients do NOT always follow the
rules
 Cpc PH Combined Pre and post capillary PH
 Group 3 and Group 2 risk factors/ disease
 IS PAH really PAH?
 Relative Severity of each component or factor
 Would we think about this differently if the lung
disease was ILD and not COPD.
 If the 2nd cath was first cath
 If initial wedge was 20 and not 30
Does the Data Make Sense
and is Data accurate
 Timing of the data
 During hospitalization with some concomitant illness
 Rapid diuresis and wedge pressure looks OK
 Initial CXR suggests otherwise
 Re equilibrate
 Inconsistencies of data
 Echo looks bad Cardiac output is good
 CT or other testing suggest other disease process

PH in the Real World - Case Studies

  • 1.
    PH in theReal World Case Studies Terry Fortin MD Duke Pulmonary Vascular Disease Center November 4, 2022
  • 2.
    • Mean PAP> 20 mmHg 1 • Wedge < 15 mmHg 2 • PVR > 3 WU (or less) 3 Definition of PAH Clinical, Hemodynamic 6th World Symposium 2018 6th World Symposium on PH 2018
  • 3.
    Groups of PH(Framework)  1. Pulmonary Arterial Hypertension (PAH)  2. PH owing to left heart disease  3. PH owing to lung diseases and/or hypoxia  4. Chronic thromboembolic pulmonary hypertension (CTEPH)  5. PH with unclear multifactorial mechanisms  (ESRD, Cancer, Hemoglobinopathy, Sarcoid…
  • 4.
    Real World :PH or PAH ? 54 yo sickle cell/thallasemia Hgb 7-8 Rheumatoid arthritis SLE overlap/MCTD CKD on hemodialysis (high output) History Mitral Valve replacement for remote endocarditis Morbid obesity, (BMI>50) OSA on CPAP LV EF is 45%, HTN, DM, TIA, CAD Pulmonary embolus x 2 but VQ neg PFDs with moderate restrictive/ obstructive lung disease. Later develops cirrhosis
  • 5.
    WCM How didwe get from A to B. What if B came first?  RH Cath 4/22  RA 22  RV 110/20  PA 104/45 mean 68  PCWP 28  Output 7 L/min  Index 3.2  PVR 5.7 WU  ABG 7.25/90/107  Hgb 17.9  RH Cath 7/22  RA 8  RV 50/10  PA 52/29 mean 34  Wedge 14  output 5.2 L/min  Index 2.5  PVR 3.9
  • 6.
    WCM 4/2022  65yo presents to OSH with “COPD flare and NSTEMI”  EMS called nonresponsive, 02 sat 60% Placed on BiPAP  History COPD since 2017, Flare 1-2 times per year . Not on 02  At OSH ABG 7.1/88/124 on 02  Elevated troponins, LFTs, AKI, pBNP 1700, Hgb 18  CT ruled out PE, No pneumonia  History of sleep apnea x years but never used machine  On inhalers for COPD No PFDs  On transfer hypercarbic and hypoxic respiratory failure.  Diuresis, on /off bipap, ABX and Steroids
  • 7.
  • 11.
    WCM Right andLeft Heart Cath 4/2022 Off BIPAP on FI02 30%  RA 22  RV 110/20  PA 104/45 mean 68  PCWP 28  AO 129/80 mean 96  CO 7 L/min CI 3.2  PVR 5.7 WU No Step up to suggest Shunt  7.25/90/107 Hgb 17.9 Sat 95%  Placed back on BIPAP post case  Two vessel CAD TIMI 3 Flow 80% mid LCx,  Tandom 80% RCA proximal and mid lesions  Negative volume about 3 liters+ by this time
  • 12.
    Pulmonary Vascular Resistance(PVR) increases with hypoxemia, acidosis, hypercarbia, increased catacholamines or sympathetic tone Illness , inflammation, Thrombosis  Very high or low lung volumes increase PVR Activation of neurohormones negatively impacts function of RV as well Relevant principles
  • 13.
    Treatment???  Diuresis  Givepulmonary vasodilator (inhaled prostacyclin)  1 and then 2  Diuresis, initiate CPAP/BIPAP/Trilogy  IV Prostacyclin  Dual oral therapy with endothelin antagonist and PDE 5 inhibitor  Repeat Cath before Discharge?  More Work up  CT with No PE, ANA normal, HIV normal, Some ongoing work up for liver disease  Had stents to his RCA and LCx
  • 14.
    My Plan  Diuresis Sent home with Trilogy Machine  02 for exertion Per PT assessment  Shock Liver resolved. AKI resolved  VBG before Discharge 7.43 pC02 48 post using trilogy in hospital  Follow up with Pulmonologist / Sleep  Seen back in my clinic in 10 Days  Decreased diuretic, pBNP much improved  Feeling best he has been in years  Plan for repeat Right heart cath after on his Sleep machine for 2 to 3 months as long as he is well
  • 15.
    WCM 1st clinicvisit  PFDs Group 3 Disease  FVC 3.33 L 76%  FEV1 1.28 L 38%  FEV1/FVC 38  FEF25-7% 14%  TLC 110%  RV 178%  DLCO 13.72 52%  Walk is 393 meters (76% predicated)room air
  • 16.
    WCM RH Cath7/2022  RA 8, PA 52/29 mean 34, Wedge 14  Cardiac output is 5.2L/min with index of 2.4  PVR is 3.9 WU, SVR 13 with mean BP of 78  TPG 20, DPG 15  pBNP is 148 ( down from 1700)  Previous cath pre trilogy and diuresis  RA 22, Mean PAP 68, wedge 28 (group 2)
  • 17.
     Passive orPost Capillary pressures cause congestion of venous bed and passive PH  Increased PA pressure with high wedge normal PVR  Can then have reversible vasoconsttriction  TPG < 12 and /or DPD or DPG <7 Reactive or precapillary PH physiologic/anatomic remodeling of arterioles to compensate or protect upstream pulmonary venous changes  PVR>3, TPG >12, DPD or DPG >7  Early may be reversible and more Chronic irreversible  Combined pre and post capillary PH Group 2 Pulmonary HTN
  • 18.
    WCM Sep 2022 Normalization of p BNP pBNP 143 ( < 225 normal)  ANA negative, Alpha -1 Antitrypsin normal  Negative VQ  Bicarb decreased from 35 to 27  Work up for Liver Disease /Steatohepatitis  Completed cardiopulmonary Rehab  No Hospitalizations or COPD flares since 4/22  Compliant with CPAP  Set up for echo next visit
  • 19.
    WCM  What GroupAt least Group 2 and 3 ?1  Pre and post capillary PH Initially more Pre  TPG 68-28 =44  DPG 45-24 = 11  But high wedge 28  Does it matter that his pH was 7.25, and pC02 90?  Group 3  Sleep issues  COPD ( Would this be different if ILD)  VQ was low probability
  • 20.
    Patients do NOTalways follow the rules  Cpc PH Combined Pre and post capillary PH  Group 3 and Group 2 risk factors/ disease  IS PAH really PAH?  Relative Severity of each component or factor  Would we think about this differently if the lung disease was ILD and not COPD.  If the 2nd cath was first cath  If initial wedge was 20 and not 30
  • 21.
    Does the DataMake Sense and is Data accurate  Timing of the data  During hospitalization with some concomitant illness  Rapid diuresis and wedge pressure looks OK  Initial CXR suggests otherwise  Re equilibrate  Inconsistencies of data  Echo looks bad Cardiac output is good  CT or other testing suggest other disease process